1. Home
  2. MORN vs BLCO Comparison

MORN vs BLCO Comparison

Compare MORN & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morningstar Inc.

MORN

Morningstar Inc.

HOLD

Current Price

$172.61

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.17

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MORN
BLCO
Founded
1984
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.4B
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
MORN
BLCO
Price
$172.61
$16.17
Analyst Decision
Strong Buy
Buy
Analyst Count
2
11
Target Price
$256.50
$18.45
AVG Volume (30 Days)
339.9K
348.0K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
1.07%
N/A
EPS Growth
3.38
N/A
EPS
2.73
N/A
Revenue
$2,445,500,000.00
$5,101,000,000.00
Revenue This Year
$9.14
$8.65
Revenue Next Year
$7.23
$5.59
P/E Ratio
$61.38
N/A
Revenue Growth
7.49
6.47
52 Week Low
$141.49
$13.09
52 Week High
$289.61
$18.92

Technical Indicators

Market Signals
Indicator
MORN
BLCO
Relative Strength Index (RSI) 54.78 51.14
Support Level $161.01 $15.36
Resistance Level $180.63 $16.64
Average True Range (ATR) 6.00 0.46
MACD 0.69 -0.08
Stochastic Oscillator 69.57 26.16

Price Performance

Historical Comparison
MORN
BLCO

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment insights to financial advisers, asset managers, and investors. It provides data and research insights on various investment offerings, including managed investment products, publicly listed companies, private capital markets, debt securities, and real-time market data. The company has five reportable segments: Morningstar Direct Platform, PitchBook, Morningstar Credit, Morningstar Wealth, and Morningstar Retirement. Maximum revenue is derived from the Morningstar Direct Platform, which provides investors with comprehensive data, research, insights, and investment analysis through product areas such as Morningstar Data, Morningstar Direct, and Morningstar Advisor Workstation. Geographically, it generates maximum revenue from the USA.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: